| Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal) | TA1144 | | |
| Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment | HTG776 | | |
| Fetal monitoring in labour | NG229 | | |
| Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over | TA1140 | | |
| Pegzilarginase for treating arginase-1 deficiency in people 2 years and over | HST35 | | |
| Hypertension in adults: diagnosis and management | NG136 | | |
| Canagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) | TA1137 | | |
| Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years (terminated appraisal) | TA1135 | | |
| Type 2 diabetes in adults: management | NG28 | | |
| Type 2 diabetes in adults | QS209 | | |
| Ruxolitinib for treating moderate to severe chronic graft versus host disease after an allogeneic stem cell transplant in people 28 days to 17 years (terminated appraisal) | TA1132 | | |
| Concizumab for treating haemophilia A or B in people 12 years and over with factor inhibitors (terminated appraisal) | TA1124 | | |
| Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal) | TA972 | | |
| Depemokimab for treating chronic rhinosinusitis with nasal polyps in adults (terminated appraisal) | TA1123 | | |
| Entrectinib for treating NTRK fusion-positive solid tumours in people 12 years and over (terminated appraisal) | TA1118 | | |
| VA ECMO for postcardiotomy cardiogenic shock in adults | HTG762 | | |
| Child maltreatment: when to suspect maltreatment in under 18s | CG89 | | |
| Suspected sepsis in pregnant or recently pregnant people: recognition, diagnosis and early management | NG255 | | |
| Suspected sepsis in people aged 16 or over: recognition, assessment and early management | NG253 | | |
| Suspected sepsis in under 16s: recognition, diagnosis and early management | NG254 | | |
| Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal) | TA1111 | | |
| Suspected sepsis in over 16s | QS213 | | |
| Cabotegravir for preventing HIV-1 in adults and young people | TA1106 | | |
| Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal) | TA1104 | | |
| Clascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal) | TA1105 | | |
| VA ECMO for severe acute heart failure in adults | HTG764 | | |
| VA ECMO for extracorporeal cardiopulmonary resuscitation (ECPR) in adults with refractory cardiac arrest | HTG765 | | |
| Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over | TA1101 | | |
| Mirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal) | TA1100 | | |
| Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable | TA1098 | | |
| Atopic eczema in under 12s: diagnosis and management | CG57 | | |
| Chronic heart failure in adults: diagnosis and management | NG106 | | |
| Chronic heart failure in adults | QS9 | | |
| Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management | NG237 | | |
| Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over | TA1093 | | |
| Bed frames for adults in acute medical or surgical hospital wards: late-stage assessment | HTG759 | | |
| Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over | TA1085 | | |
| Cenobamate for treating focal onset seizures in epilepsy | TA753 | | |
| Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment | HTG753 | | |
| Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over | TA1077 | | |
| Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies | TA1073 | | |
| Headaches in over 12s: diagnosis and management | CG150 | | |
| Somapacitan for treating growth hormone deficiency in people 3 to 17 years | TA1066 | | |
| Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma | TA1059 | | |
| Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal) | TA1061 | | |
| Falls: assessment and prevention in older people and in people 50 and over at higher risk | NG249 | | |
| Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over | HST33 | | |
| Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal) | TA1058 | | |
| Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over | TA1054 | | |
| Burosumab for treating X-linked hypophosphataemia in children and young people | HST8 | | |
| Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over | TA1051 | | |
| Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal) | TA1052 | | |
| Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over | TA1050 | | |
| Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over | TA1044 | | |
| Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over | TA1033 | | |
| Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over | TA1038 | | |
| Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and over | TA1039 | | |
| Artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment | HTG696 | | |
| Epilepsies in children, young people and adults | NG217 | | |
| Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease | TA1035 | | |
| Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours | TA1034 | | |
| Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over | TA1031 | | |
| Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years | NG247 | | |
| Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal) | TA1029 | | |
| Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessment | HTG739 | | |
| Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adults | HTG738 | | |
| MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's | HTG733 | | |
| Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis | TA1018 | | |
| Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and over | TA1019 | | |
| Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices | HTG730 | | |
| Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) | TA1006 | | |
| Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over | TA1002 | | |
| Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and over | TA1003 | | |
| Burosumab for treating X-linked hypophosphataemia in adults | TA993 | | |
| Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over | TA986 | | |
| Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal) | TA982 | | |
| Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal) | TA980 | | |
| Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over | TA977 | | |
| Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome | HST31 | | |
| Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes | HTG721 | | |
| Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and under | TA975 | | |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | HTG719 | | |
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | HTG708 | | |
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over | TA967 | | |
| Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal) | TA960 | | |
| Ritlecitinib for treating severe alopecia areata in people 12 years and over | TA958 | | |
| Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis | TA959 | | |
| Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment | HTG713 | | |
| Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over | TA956 | | |
| Vitamin B12 deficiency in over 16s: diagnosis and management | NG239 | | |
| Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over | TA949 | | |
| Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over | TA950 | | |
| Intravascular lithotripsy for calcified arteries in peripheral arterial disease | HTG707 | | |
| Epilepsies in children, young people and adults | QS211 | | |
| Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | TA943 | | |
| Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal) | TA938 | | |
| Transient loss of consciousness ('blackouts') in over 16s | CG109 | | |
| Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | CG164 | | |
| Jaundice in newborn babies under 28 days | CG98 | | |
| Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) | QS210 | | |
| Stroke rehabilitation in adults | NG236 | | |
| Urinary incontinence in neurological disease: assessment and management | CG148 | | |
| Hearing loss in adults: assessment and management | NG98 | | |
| KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment | HTG694 | | |
| Chronic obstructive pulmonary disease in adults | QS10 | | |
| Cirrhosis in over 16s: assessment and management | NG50 | | |
| Otitis media with effusion in under 12s | NG233 | | |
| Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | HTG690 | | |
| Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment | HTG665 | | |
| Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal) | TA910 | | |
| Artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | HTG687 | | |
| Oesophago-gastric cancer: assessment and management in adults | NG83 | | |
| Depression in adults | QS8 | | |
| Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young people | HTG684 | | |
| YOURmeds for medication support in long-term conditions | MIB289 | | |
| Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over | TA893 | | |
| Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal) | TA899 | | |
| Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | HTG677 | | |
| Difelikefalin for treating pruritus in people having haemodialysis | TA890 | | |
| Diabetes (type 1 and type 2) in children and young people: diagnosis and management | NG18 | | |
| Metastatic malignant disease of unknown primary origin in adults: diagnosis and management | CG104 | | |
| Hypertension in pregnancy: diagnosis and management | NG133 | | |
| Finerenone for treating chronic kidney disease in type 2 diabetes | TA877 | | |
| CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment | HTG663 | | |
| Type 1 diabetes in adults | QS208 | | |
| Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma | TA874 | | |
| Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene | HST22 | | |
| Urinary tract infections in adults | QS90 | | |
| Somatrogon for treating growth disturbance in children and young people aged 3 years and over | TA863 | | |
| Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
| Diabetes in pregnancy | QS109 | | |
| Hip fracture in adults | QS16 | | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes | MIB312 | | |
| Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis | HTG648 | | |
| Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder | HTG645 | | |
| Osteoarthritis in over 16s: diagnosis and management | NG226 | | |
| Osteoarthritis in over 16s | QS87 | | |
| O2matic PRO 100 for optimising oxygen treatment in respiratory conditions | MIB308 | | |
| Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas | CG118 | | |
| Focal resurfacing implants to treat articular cartilage damage in the knee | HTG635 | | |
| Type 1 diabetes in adults: diagnosis and management | NG17 | | |
| Urinary tract infection in under 16s: diagnosis and management | NG224 | | |
| Fever in under 5s | QS64 | | |
| Urinary tract infection in children and young people | QS36 | | |
| Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease | TA809 | | |
| Roxadustat for treating symptomatic anaemia in chronic kidney disease | TA807 | | |
| Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides | TA805 | | |
| Social, emotional and mental wellbeing in primary and secondary education | NG223 | | |
| Depression in adults: treatment and management | NG222 | | |
| Vertebral body tethering for idiopathic scoliosis in children and young people | HTG628 | | |
| Multiple sclerosis in adults: management | NG220 | | |
| Endoanchoring systems in endovascular aortic aneurysm repair | HTG625 | | |
| Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome | HTG623 | | |
| Vaccine uptake in the general population | NG218 | | |
| Vaccine uptake in under 19s | QS145 | | |
| Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults | ES40 | | |
| Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over | HST20 | | |
| Stroke and transient ischaemic attack in over 16s: diagnosis and initial management | NG128 | | |
| Diabetes in children and young people | QS125 | | |
| EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | HTG611 | | |
| Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable | TA763 | | |
| Microwave ablation for primary or metastatic cancer in the lung | HTG609 | | |
| Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care | HTG607 | | |
| Urinary incontinence in women | QS77 | | |
| Brain tumours (primary) and brain metastases in over 16s | QS203 | | |
| Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders | TA748 | | |
| Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) | TA749 | | |
| clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia | MIB278 | | |
| CerebAir for continuous EEG monitoring in intensive care | MIB279 | | |
| Fever in under 5s: assessment and initial management | NG143 | | |
| Heart valve disease presenting in adults: investigation and management | NG208 | | |
| Secukinumab for treating moderate to severe plaque psoriasis in children and young people | TA734 | | |
| DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography | HTG594 | | |
| Sapropterin for treating hyperphenylalaninaemia in phenylketonuria | TA729 | | |
| Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis | HTG592 | | |
| Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair | HTG593 | | |
| Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s | NG202 | | |
| Venous thromboembolism in adults | QS201 | | |
| Melatonin for treating sleep disorders in adults who are blind | ES38 | | |
| MMprofiler for prognostic risk classification in multiple myeloma | MIB270 | | |
| Bronchiolitis in children: diagnosis and management | NG9 | | |
| Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation | TA249 | | |
| Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation | TA355 | | |
| Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation | TA256 | | |
| Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation | TA275 | | |
| Patient experience in adult NHS services: improving the experience of care for people using adult NHS services | CG138 | | |
| Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
| Autism spectrum disorder in under 19s: support and management | CG170 | | |
| Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal) | TA701 | | |
| Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers | HTG355 | | |
| Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults | HTG577 | | |
| Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver | HTG575 | | |
| Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain | NG193 | | |
| Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury | HTG568 | | |
| Safeguarding adults in care homes | NG189 | | |
| Brain tumours (primary) and brain metastases in over 16s | NG99 | | |
| Artificial intelligence in mammography | MIB242 | | |
| Diabetes in pregnancy: management from preconception to the postnatal period | NG3 | | |
| Cytosponge for detecting abnormal cells in the oesophagus | MIB240 | | |
| Low back pain and sciatica in over 16s: assessment and management | NG59 | | |
| Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal) | TA662 | | |
| QuickChange Incontinence Wrap for urinary incontinence in men | MIB237 | | |
| Acute coronary syndromes in adults | QS68 | | |
| NPi-200 for pupillary light reflex in critical care patients | MIB235 | | |
| Testing strategies for Lynch syndrome in people with endometrial cancer | HTG557 | | |
| Rheumatoid arthritis in adults: management | NG100 | | |
| Neuropathic pain in adults: pharmacological management in non-specialist settings | CG173 | | |
| t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes | MIB227 | | |
| Perioperative care in adults | NG180 | | |
| Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma | TA641 | | |
| Deep brain stimulation for refractory epilepsy in adults | HTG550 | | |
| Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome | MIB223 | | |
| Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease | HTG549 | | |
| Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure | TA626 | | |
| Generalised anxiety disorder and panic disorder in adults: management | CG113 | | |
| Intravenous fluid therapy in children and young people in hospital | NG29 | | |
| Cytokine adsorption devices for treating respiratory failure in people with COVID-19 | MIB217 | | |
| TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation | MIB210 | | |
| Cor-Knot for tying suture knots in valve surgery | MIB206 | | |
| Selective internal radiation therapy for unresectable colorectal metastases in the liver | HTG542 | | |
| National Early Warning Score systems that alert to deteriorating adult patients in hospital | MIB205 | | |
| Cerebral palsy in adults | QS191 | | |
| Fetoscopic prenatal repair for open neural tube defects in the fetus | HTG536 | | |
| Open prenatal repair for open neural tube defects in the fetus | HTG537 | | |
| Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C | HTG385 | | |
| Rheumatoid arthritis in over 16s | QS33 | | |
| Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure | TA617 | | |
| PulmoVista 500 for monitoring ventilation in critical care | MIB203 | | |
| Lung cancer in adults | QS17 | | |
| AmnioSense for unexplained vaginal wetness in pregnancy | MIB198 | | |
| Rapid tests for group A streptococcal infections in people with a sore throat | HTG531 | | |
| Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management | CG184 | | |
| Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease | TA607 | | |
| MR-proADM test for use with clinical deterioration scores in cases of suspected infection | MIB195 | | |
| Gastro-oesophageal reflux disease in children and young people: diagnosis and management | NG1 | | |
| Tegaderm CHG securement dressing for vascular access sites in critically ill adults | HTG379 | | |
| SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea | MIB190 | | |
| Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | NG89 | | |
| Alcohol interventions in secondary and further education | NG135 | | |
| Service user experience in adult mental health services | QS14 | | |
| Patient experience in adult NHS services | QS15 | | |
| Chronic obstructive pulmonary disease in over 16s: diagnosis and management | NG115 | | |
| Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity | TA589 | | |
| Hypertension in pregnancy | QS35 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis | HTG521 | | |
| Hearing loss in adults | QS185 | | |
| Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies | TA171 | | |
| Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction | HTG518 | | |
| Depression in children and young people: identification and management | NG134 | | |
| Urinary incontinence and pelvic organ prolapse in women: management | NG123 | | |
| Ambu aScope4 Broncho for use in unexpected difficult airways | HTG312 | | |
| Physical activity: encouraging activity in the community | QS183 | | |
| Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer | TA584 | | |
| Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care | HTG508 | | |
| The Debrisoft monofilament debridement pad for use in acute or chronic wounds | HTG334 | | |
| Kendall DL for ECG monitoring in people having cardiac surgery | MIB177 | | |
| CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease | MIB174 | | |
| Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis | HTG501 | | |
| Path Finder for freezing of gait in people with Parkinson's disease | MIB170 | | |
| Cerebral palsy in adults | NG119 | | |
| Darvadstrocel for treating complex perianal fistulas in Crohn's disease | TA556 | | |
| Video laryngoscopes to help intubation in people with difficult airways | MIB167 | | |
| Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults | HTG493 | | |
| Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) | TA549 | | |
| Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions | HTG492 | | |
| The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs | MIB159 | | |
| Preventing suicide in community and custodial settings | NG105 | | |
| Emergency and acute medical care in over 16s | QS174 | | |
| Neon EEG electrode for EEG monitoring in newborns | MIB155 | | |
| AlignRT in breast cancer radiotherapy | MIB157 | | |
| Medicines management for people receiving social care in the community | QS171 | | |
| Biomarker tests to help diagnose preterm labour in women with intact membranes | HTG476 | | |
| Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over | NG36 | | |
| VIDAvision for lung volume analysis in emphysema | MIB148 | | |
| Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups | QS167 | | |
| Nerve transfer to partially restore upper limb function in tetraplegia | HTG466 | | |
| Emergency and acute medical care in over 16s: service delivery and organisation | NG94 | | |
| People's experience in adult social care services: improving the experience of care and support for people using adult social care services | NG86 | | |
| Mental health of adults in contact with the criminal justice system | QS163 | | |
| Pancreatic cancer in adults: diagnosis and management | NG85 | | |
| Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women | TA160 | | |
| Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women | TA161 | | |
| MammaTyper in vitro diagnostic test for determining breast cancer subtypes | MIB135 | | |
| Next-generation sequencing panel for solid tumour cancers in children | MIB133 | | |
| Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
| Endobronchial valve insertion to reduce lung volume in emphysema | HTG457 | | |
| Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease | MIB132 | | |
| Tests in secondary care to identify people at high risk of ovarian cancer | HTG453 | | |
| HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer | MIB128 | | |
| Cataracts in adults: management | NG77 | | |
| Immunosuppressive therapy for kidney transplant in adults | TA481 | | |
| Immunosuppressive therapy for kidney transplant in children and young people | TA482 | | |
| Cerebral palsy in children and young people | QS162 | | |
| Thora-3Di for assessing asthma in children | MIB122 | | |
| Faltering growth: recognition and management of faltering growth in children | NG75 | | |
| Type 2 diabetes: prevention in people at high risk | PH38 | | |
| Physical health of people in prisons | QS156 | | |
| Rehabilitation after critical illness in adults | QS158 | | |
| Vitamin D: supplement use in specific population groups | PH56 | | |
| Low back pain and sciatica in over 16s | QS155 | | |
| Chronic kidney disease in adults | QS5 | | |
| Parkinson's disease in adults | NG71 | | |
| Constipation in children and young people: diagnosis and management | CG99 | | |
| Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people | TA455 | | |
| New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | HTG281 | | |
| Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult | MIB53 | | |
| Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult | MIB54 | | |
| Violent and aggressive behaviours in people with mental health problems | QS154 | | |
| Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease | TA449 | | |
| Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | HTG441 | | |
| RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease | MIB109 | | |
| Oral health in care homes | QS151 | | |
| Spondyloarthritis in over 16s: diagnosis and management | NG65 | | |
| Idiopathic pulmonary fibrosis in adults: diagnosis and management | CG163 | | |
| Intravenous fluid therapy in adults in hospital | CG174 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
| Managing medicines for adults receiving social care in the community | NG67 | | |
| Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | | |
| Mitochondrial disorders in children: Co-enzyme Q10 | ES11 | | |
| Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women | HTG434 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Narcolepsy with or without cataplexy in adults: pitolisant | ES8 | | |
| Skin involvement in systemic sclerosis: rituximab | ES7 | | |
| SimpliCT laser-guided needle placement in interventional radiology | MIB98 | | |
| Care of dying adults in the last days of life | QS144 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | HTG430 | | |
| Lateral interbody fusion in the lumbar spine for low back pain | HTG431 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
| Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis | MIB93 | | |
| Oral health promotion in the community | QS139 | | |
| Hypothermia: prevention and management in adults having surgery | CG65 | | |
| Spasticity in under 19s: management | CG145 | | |
| Sternal Talon for sternal closure in cardiothoracic surgery | MIB88 | | |
| Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | | |
| Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | | |
| Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | | |
| Physical health of people in prison | NG57 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma | TA414 | | |
| Single-incision short sling mesh insertion for stress urinary incontinence in women | HTG419 | | |
| Woundchek Protease Status for assessing elevated protease status in chronic wounds | MIB83 | | |
| Intravenous fluid therapy in children and young people in hospital | QS131 | | |
| QuikRead go for C-reactive protein testing in primary care | MIB78 | | |
| Alere Afinion CRP for C-reactive protein testing in primary care | MIB81 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
| Early years: promoting health and wellbeing in under 5s | QS128 | | |
| Nivolumab in combination with ipilimumab for treating advanced melanoma | TA400 | | |
| Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
| Oral health for adults in care homes | NG48 | | |
| Bronchiolitis in children | QS122 | | |
| Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma | TA396 | | |
| Stroke in adults | QS2 | | |
| TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation | MIB60 | | |
| ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation | MIB61 | | |
| Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis | TA386 | | |
| Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | HTG405 | | |
| Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetron | ESNM69 | | |
| Bipolar disorder in adults | QS95 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | HTG401 | | |
| MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes | MIB51 | | |
| Irritable bowel syndrome in adults | QS114 | | |
| Gastro-oesophageal reflux in children and young people | QS112 | | |
| Preventing unintentional injury in under 15s | QS107 | | |
| C3 glomerulopathy in the native kidney: eculizumab | ESUOM49 | | |
| Care of dying adults in the last days of life | NG31 | | |
| Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) | ESNM65 | | |
| Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
| Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes | HTG389 | | |
| Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset | NG16 | | |
| Bipolar disorder, psychosis and schizophrenia in children and young people | QS102 | | |
| Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
| i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department | MIB38 | | |
| Hypertension in adults | QS28 | | |
| Visensia for early detection of deteriorating vital signs in adults in hospital | MIB36 | | |
| Dyspepsia and gastro‑oesophageal reflux disease in adults | QS96 | | |
| Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section | HTG380 | | |
| Everolimus for preventing organ rejection in liver transplantation | TA348 | | |
| Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) | TA351 | | |
| BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis | MIB32 | | |
| Lower urinary tract symptoms in men: management | CG97 | | |
| Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia | TA343 | | |
| Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
| Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation | HTG369 | | |
| Insertion of endobronchial nitinol coils to improve lung function in emphysema | HTG370 | | |
| The PediGuard for placing pedicle screws in spinal surgery | MIB26 | | |
| Alcohol: preventing harmful use in the community | QS83 | | |
| Medicines management in care homes | QS85 | | |
| Empagliflozin in combination therapy for treating type 2 diabetes | TA336 | | |
| Psychosis and schizophrenia in adults | QS80 | | |
| Idiopathic pulmonary fibrosis in adults | QS79 | | |
| The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancer | MIB16 | | |
| The Space GlucoseControl system for managing blood‑glucose in critically ill patients in intensive care | MIB17 | | |
| Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects | HTG357 | | |
| Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy | TA323 | | |
| Nalmefene for reducing alcohol consumption in people with alcohol dependence | TA325 | | |
| The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease | MIB12 | | |
| The SENSIMED Triggerfish contact lens sensor for continuous 24-hour recording of ocular dimensional changes in people with or at risk of developing glaucoma | MIB14 | | |
| Management of vomiting in children and young people with gastroenteritis: ondansetron | ESUOM34 | | |
| Transient loss of consciousness ('blackouts') in over 16s | QS71 | | |
| Promoting tolerance of enteral feeds in children and young people: domperidone | ESUOM18 | | |
| Bedwetting in children and young people | QS70 | | |
| Intravenous fluid therapy in adults in hospital | QS66 | | |
| Varicose veins in the legs | QS67 | | |
| Delirium in adults | QS63 | | |
| Safe staffing for nursing in adult inpatient wards in acute hospitals | SG1 | | |
| Canagliflozin in combination therapy for treating type 2 diabetes | TA315 | | |
| Constipation in children and young people | QS62 | | |
| Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | | |
| Antisocial behaviour and conduct disorders in children and young people | QS59 | | |
| Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis | TA308 | | |
| Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy | TA307 | | |
| Psychosis and schizophrenia in adults: prevention and management | CG178 | | |
| Managing medicines in care homes | SC1 | | |
| Jaundice in newborn babies under 28 days | QS57 | | |
| Faecal incontinence in adults | QS54 | | |
| Mental wellbeing of older people in care homes | QS50 | | |
| Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people | TA300 | | |
| Phrenic nerve transfer in brachial plexus injury | HTG322 | | |
| Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment | ESUOM21 | | |
| Postural hypotension in adults: fludrocortisone | ESUOM20 | | |
| Depression in children and young people | QS48 | | |
| Lower urinary tract symptoms in men | QS45 | | |
| Atopic eczema in under 12s | QS44 | | |
| Headaches in over 12s | QS42 | | |
| EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | HTG316 | | |
| Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | HTG315 | | |
| Acute upper gastrointestinal bleeding in adults | QS38 | | |
| Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder | TA292 | | |
| Gastroparesis in adults: oral erythromycin | ESUOM13 | | |
| Physical activity: brief advice for adults in primary care | PH44 | | |
| Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer | TA284 | | |
| Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer | TA285 | | |
| Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis | TA276 | | |
| Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) | TA277 | | |
| Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma | HTG305 | | |
| Irreversible electroporation for treating primary lung cancer and metastases in the lung | HTG302 | | |
| Polycystic ovary syndrome: metformin in women not planning pregnancy | ESUOM6 | | |
| Nutrition support in adults | QS24 | | |
| Drug use disorders in adults | QS23 | | |
| Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours | TA265 | | |
| Neutropenic sepsis: prevention and management in people with cancer | CG151 | | |
| Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer | TA263 | | |
| Sickle cell disease: managing acute painful episodes in hospital | CG143 | | |
| Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2 | TA257 | | |
| Botulinum toxin type A for the prevention of headaches in adults with chronic migraine | TA260 | | |
| Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation | HTG286 | | |
| Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services | CG136 | | |
| Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants | HTG276 | | |
| Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease | TA223 | | |
| Extracorporeal membrane oxygenation for severe acute respiratory failure in adults | HTG260 | | |
| Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings | CG120 | | |
| Food allergy in under 19s: assessment and diagnosis | CG116 | | |
| Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer | TA214 | | |
| Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years | TA213 | | |
| Thoracoscopic repair of congenital diaphragmatic hernia in neonates | HTG247 | | |
| Sedation in under 19s: using sedation for diagnostic and therapeutic procedures | CG112 | | |
| Prucalopride for the treatment of chronic constipation in women | TA211 | | |
| Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers | HTG243 | | |
| Selective dorsal rhizotomy for spasticity in cerebral palsy | HTG245 | | |
| Unintentional injuries in the home: interventions for under 15s | PH30 | | |
| Bedwetting in under 19s | CG111 | | |
| Denosumab for the prevention of osteoporotic fractures in postmenopausal women | TA204 | | |
| Percutaneous intradiscal laser ablation in the lumbar spine | HTG230 | | |
| Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism | HTG222 | | |
| Human growth hormone (somatropin) for the treatment of growth failure in children | TA188 | | |
| Prosthetic intervertebral disc replacement in the cervical spine | HTG217 | | |
| Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes | TA47 | | |
| Depression in adults with a chronic physical health problem: recognition and management | CG91 | | |
| Prosthetic intervertebral disc replacement in the lumbar spine | HTG197 | | |
| Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management | CG84 | | |
| Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD) | HTG189 | | |
| Rehabilitation after critical illness in adults | CG83 | | |
| Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | CG76 | | |
| Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
| Physical activity in the workplace | PH13 | | |
| Structural neuroimaging in first-episode psychosis | TA136 | | |
| Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates | HTG158 | | |
| Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children | HTG149 | | |
| Acutely ill adults in hospital: recognising and responding to deterioration | CG50 | | |
| Drug misuse in over 16s: opioid detoxification | CG52 | | |
| Drug misuse in over 16s: psychosocial interventions | CG51 | | |
| Faecal incontinence in adults: management | CG49 | | |
| Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy | TA117 | | |
| High-intensity focused ultrasound for atrial fibrillation in association with other cardiac surgery | HTG119 | | |
| High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer | HTG113 | | |
| Capecitabine and oxaliplatin in the adjuvant treatment of stage 3 (Dukes' C) colon cancer | TA100 | | |
| Stent-graft placement in abdominal aortic aneurysm | HTG106 | | |
| Intraoperative blood cell salvage in obstetrics | HTG90 | | |
| Intramural urethral bulking procedures for stress urinary incontinence in women | HTG86 | | |
| Improving outcomes in children and young people with cancer | CSG7 | | |
| Endovascular stent–graft placement in thoracic aortic aneurysms and dissections | HTG76 | | |
| Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery | HTG72 | | |
| Cryoablation for atrial fibrillation in association with other cardiac surgery | HTG74 | | |
| Microwave ablation for atrial fibrillation in association with other cardiac surgery | HTG73 | | |
| Guidance on the use of paclitaxel in the treatment of ovarian cancer | TA55 | | |
| Improving outcomes in head and neck cancers | CSG6 | | |
| Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children | HTG45 | | |
| Balloon angioplasty of pulmonary vein stenosis in infants | HTG46 | | |
| Balloon dilatation of systemic to pulmonary arterial shunts in children | HTG48 | | |
| Balloon valvuloplasty for aortic valve stenosis in adults and children | HTG49 | | |
| Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children | HTG47 | | |
| Vagus nerve stimulation for refractory epilepsy in children | HTG25 | | |
| Pre-hospital initiation of fluid replacement therapy in trauma | TA74 | | |
| Extracorporeal membrane oxygenation (ECMO) in postneonatal children | HTG17 | | |
| Human growth hormone (somatropin) in adults with growth hormone deficiency | TA64 | | |
| Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction | TA52 | | |